CA934663A - Compositions for the treatment of depressive illness - Google Patents

Compositions for the treatment of depressive illness

Info

Publication number
CA934663A
CA934663A CA064057A CA64057A CA934663A CA 934663 A CA934663 A CA 934663A CA 064057 A CA064057 A CA 064057A CA 64057 A CA64057 A CA 64057A CA 934663 A CA934663 A CA 934663A
Authority
CA
Canada
Prior art keywords
compositions
treatment
depressive illness
depressive
illness
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA064057A
Other languages
English (en)
Inventor
A. X. Cocheme Manuel
J. Coppen Alec
Ogden Arthur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CAMBRIAN CHEMICALS Ltd
Original Assignee
CAMBRIAN CHEMICALS Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CAMBRIAN CHEMICALS Ltd filed Critical CAMBRIAN CHEMICALS Ltd
Application granted granted Critical
Publication of CA934663A publication Critical patent/CA934663A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA064057A 1968-10-03 1969-10-02 Compositions for the treatment of depressive illness Expired CA934663A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB4704268 1968-10-03
GB266069 1969-01-16

Publications (1)

Publication Number Publication Date
CA934663A true CA934663A (en) 1973-10-02

Family

ID=26237645

Family Applications (1)

Application Number Title Priority Date Filing Date
CA064057A Expired CA934663A (en) 1968-10-03 1969-10-02 Compositions for the treatment of depressive illness

Country Status (7)

Country Link
BE (1) BE739613A (enExample)
CA (1) CA934663A (enExample)
DE (1) DE1949774A1 (enExample)
ES (1) ES372150A1 (enExample)
FR (1) FR2019845A1 (enExample)
IE (1) IE33333B1 (enExample)
NL (1) NL6914820A (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE14837T1 (de) * 1981-10-05 1985-08-15 Alec James Coppen Pharmazeutische zusammensetzungen.
HU191598B (en) * 1984-03-20 1987-03-30 Egyt Gyogyszervegyeszeti Gyar Method for the preparation of injection solution suitable preferably against cathosis
CA2410966C (en) * 2002-11-01 2005-11-22 Craig J. Hudson Sexual desire and performance enhancement with protein-bound tryptophan

Also Published As

Publication number Publication date
NL6914820A (enExample) 1970-04-07
DE1949774A1 (de) 1970-05-27
ES372150A1 (es) 1971-12-16
IE33333B1 (en) 1974-05-29
FR2019845A1 (en) 1970-07-10
FR2019845B1 (enExample) 1973-01-12
IE33333L (en) 1970-04-03
BE739613A (enExample) 1970-03-02

Similar Documents

Publication Publication Date Title
CA934663A (en) Compositions for the treatment of depressive illness
AU446006B2 (en) Compositions forthe treatment of depressive illness
AU6151369A (en) Compositions forthe treatment of depressive illness
CA793280A (en) Compositions for the treatment of dandruff
CA789662A (en) Treatment of surfaces
CA931500A (en) Treatment of chlorine
CA787808A (en) Treatment of pigments
CA688702A (en) Organosiloxane treatment of vitreous surfaces
CA789518A (en) Surface treatment of polyesters
CA793873A (en) Treatment of fats
CA784515A (en) Treatment of onions
CA795282A (en) Treatment of glass surfaces
AU290264B2 (en) Treatment of shaped articles
CA855680A (en) Treatment of surfaces
CA775473A (en) Treatment of ticl4
AU433491B2 (en) Manufacture of semiconductors
AU4121368A (en) Improvements inthe treatment of tinplate
CA787112A (en) Asbestos treatment
CA776623A (en) Disinfecting compositions
CA783519A (en) Treatment of glass
CA783515A (en) Treatment of glass
CA802126A (en) Treatment of glass
CA800574A (en) Treatment of metal surfaces
CA790106A (en) Treatment of metal surfaces
CA790553A (en) Treatment of metal surfaces